Zacytuj

1. Kim NR, Lee MS, Yoon YC, Kim DS, Lee KS, Suh GY, et al. Alveolar soft part sarcoma of the lung. :6.Search in Google Scholar

2. Ogose A, Morita T, Hotta T, Kobayashi H, Otsuka H, Hirata Y, et al. Brain metastases in musculoskeletal sarcomas. Japnese Journal of Clinical Oncology. 1999;29(5): 245–247.10.1093/jjco/29.5.245Search in Google Scholar

3. Cohen DB, Jones DM, Fergus AH, Qian J, Schwartz MS. Meta-static alveolar soft-part sarcoma of the intracranial skull base: case report. Skull Base. 2002;12(01): 33–38.10.1055/s-2002-21571Search in Google Scholar

4. Ordóñez NG, Mackay B. Alveolar soft-part sarcoma: a review of the pathology and histogenesis. Ultrastructural Pathology. 1998;22(4): 275–292.10.3109/01913129809103349Search in Google Scholar

5. Tsutsumi Y, Deng Y. Alveolar soft part sarcoma of the pulmonary vein. Pathology International. 2008;41(10): 771–777.10.1111/j.1440-1827.1991.tb03350.xSearch in Google Scholar

6. Sonobe H, Ro JY, Mackay B, Ordóñez NG, Rundell MM, Ayala AG. Primary pulmonary alveolar soft-part sarcoma: report of a case. International Journal of Surgical Pathology. 1994;2(1): 57–61.10.1177/106689699400200110Search in Google Scholar

7. Devisme L, Mensier E, Bisiau S, Bloget F, Gosselin B. [Alveolar sarcoma. Report of a case]. Annals of Pathology. 1996;16(1): 49–52.Search in Google Scholar

8. Trabelsi A, Abdelkrim SB, Yacoubi MT, Mlika S, Hmissa S, Mokni M, et al. Sarcome alvéolaire primitif du poumon. Revue des Maladies Respiratoires. 2009;26(3): 329–332.10.1016/S0761-8425(09)72591-4Search in Google Scholar

9. Zhao M, Rao Q, Wu C, Zhao Z, He X, Ru G. Alveolar soft part sarcoma of lung: report of a unique case with emphasis on diagnostic utility of molecular genetic analysis for TFE3 gene rearrangement and immunohistochemistry for TFE3 antigen expression. Diagnostic Pathology. 2015;10(1): 160.10.1186/s13000-015-0399-5457048626369552Search in Google Scholar

10. Rosai J, Dias P, Parham DM, Shapiro DN, Houghton P. MyoDl protein expression in alveolar soft part sarcoma as confirmatory evidence of its skeletal muscle nature. The American Journal of Surgical Pathology. 1991;15(10): 974–981.10.1097/00000478-199110000-000081656801Search in Google Scholar

11. Wang M, Li J, Huan L, Meng F, Pang Q. Alveolar soft part sarcoma associated with lung and brain metastases: a case report. Oncology Letters. 2016;12(2): 956–958.10.3892/ol.2016.4715495016027446376Search in Google Scholar

12. Fox BD, Patel A, Suki D, Rao G. Surgical management of metastatic sarcoma to the brain: clinical article. Journal of Neurosurgery. 2009;110(1): 181–186.10.3171/2008.4.1750518834268Search in Google Scholar

13. Lewis AJ. Sarcoma metastatic to the brain. Cancer. 1988;61(3): 593–601.10.1002/1097-0142(19880201)61:3<593::AID-CNCR2820610329>3.0.CO;2-ZSearch in Google Scholar

14. Perumall VV, Harun R, Sellamuthu P, Shah MS. Alveolar soft part sarcoma with brain metastases. Asian Journal of Neurosurgery. 2017;12(1): 112.10.4103/1793-5482.144197Search in Google Scholar

15. Kummar S, Allen D, Monks A, Polley EC, Hose CD, Ivy SP, et al. Cediranib for metastatic alveolar soft part sarcoma. Journal of Clinical Oncology. 2013;31(18): 2296–2302.10.1200/JCO.2012.47.4288Search in Google Scholar

16. Reichardt P, Lindner T, Pink D, Thuss-Patience PC, Kretzschmar A, Dörken B. Chemotherapy in alveolar soft part sarcomas. European Journal of Cancer. 2003;39(11): 1511–1516.10.1016/S0959-8049(03)00264-8Search in Google Scholar

eISSN:
2247-059X
Język:
Angielski
Częstotliwość wydawania:
Volume Open
Dziedziny czasopisma:
Medicine, Clinical Medicine, Internal Medicine, Pneumology, other